New Delhi, February 19 India on Thursday called for deeper cooperation in research and development, biotechnology, specialty pharmaceuticals, and advanced therapeutics with Switzerland, with the aim of further strengthening economic ties between the two countries.
Commerce and Industry Minister Piyush Goyal also sought Swiss investments in sectors where Switzerland has established niche technological strengths.
These issues were discussed during the meeting between Goyal and the President of the Swiss Confederation, Guy Parmelin, here.
Parmelin was here to attend the India AI Impact Summit 2026.
In the context of the AI Impact Summit, both sides acknowledged the need to balance innovation with responsibility, and noted that the Trade and Economic Partnership Agreement (TEPA) offers significant opportunities for technology collaboration in areas such as precision engineering, health sciences, renewable energy, innovation, and research and development.
India and the European Free Trade Association (EFTA) implemented the TEPA last year.
EFTA members are Iceland, Liechtenstein, Norway, and Switzerland.
"The Agreement opens doors for "Make in India" products to integrate into the USD 1 trillion market of Switzerland. From farmers and fishermen to forest dwellers, workers, women, youth, small businesses, and professionals, TEPA has opened doors to new opportunities and a brighter economic future," the commerce ministry said.
TEPA carries an agreed ambition to facilitate USD 100 billion in investments into India and support the creation of one million direct jobs.
